CELLESTIAL HEALTH LTD
Significant control: Nataly Hastings (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Cellestial Health Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Cellestial Health Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
CELLESTIAL HEALTH LTD is an active private limited company (company number 14811694) incorporated on 18 April 2023, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 April 2026, showing net assets of £150k and cash of £105k, with 1 employee on average. Net assets fell 55% on the prior period (£336k).
By net assets it sits in the upper half of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
Ownership and control
- Dr Nataly Hastings
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Md Saifur Rahman
- owns 25–50% of shares
- holds 25–50% of voting rights
- Przemyslaw Aleksander Stempor
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 18 April 20233 yrs ago
- Next accounts due
- 30 January 2028in 461 days
- Confirmation statement due
- 2 May 2027in 188 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2026 | £150k | £105k | £63k | £17k | — | — | 1 |
| 30 April 2025 | £336k | £304k | £61k | £29k | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £150,450 at 30 April 2026
- Net assets down 25% or more on the prior period-55.3% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 9.65
- Cash at bank of £50,000 or moreCash £104,770
- Incorporated two to five years agoIncorporated 18 April 2023
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 461 days
- Confirmation statement duein 188 days
- Accounts period endNet assets £150k · small accounts
- Accounts period endNet assets £336k · small accounts
- Incorporated
Similar companies in Cambridge
- TRUTINA THERAPEUTICS LTDCambridge · inc. Apr 2023
- BENSEN PHARMA LIMITEDNewmarket · inc. May 2023
- RNAVATE LIMITEDCambridge · inc. Mar 2023
- CYTEK BIOSCIENCES LTDEly · inc. Mar 2023
- BENSEN HOLDINGS LIMITEDNewmarket · inc. May 2023
- ENSOCELL LTDCambridge · inc. Mar 2023
All companies incorporated on 18 April 2023 · in Apr 2023.
Reminders for CELLESTIAL HEALTH LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.